Vista Gold Corp.:企業の戦略・SWOT・財務情報

◆英語タイトル:Vista Gold Corp. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4310
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:金属・鉱業
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vista Gold Corp. – Strategy, SWOT and Corporate Finance Report
Summary

Vista Gold Corp. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vista Gold Corp. (Vista) is a gold mining company. It carries out the gold exploration, acquisition, development and operations in Australia. The company operates through its Mt. Todd gold project, which is largest undeveloped gold project in Australia. It is a brownfield development project with significant infrastructure including paved access, and a natural gas pipeline. The company operates this project through its subsidiary Vista Gold Australia Pty Ltd. The project includes Batman Deposit, Heap Leach Pad and Quigleys Deposit. Moreover, the company also holds royalty interests in projects in the US and Indonesia. Vista is headquartered in Littleton, Colorado, the US.

Scope

- Detailed information on Vista Gold Corp. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vista Gold Corp. in the form of a SWOT analysis
- An in-depth view of the business model of Vista Gold Corp. including a breakdown and examination of key business segments
- Intelligence on Vista Gold Corp.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vista Gold Corp., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vista Gold Corp. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vista Gold Corp. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vista Gold Corp.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Vista Gold Corp.: Company Overview 9
Vista Gold Corp.: Overview and Key Facts 9
Vista Gold Corp.: Overview 9
Vista Gold Corp.: Key Facts 9
Vista Gold Corp.: Key Employees 11
Vista Gold Corp.: Key Employee Biographies 12
Vista Gold Corp.: Major Products and Services 13
Vista Gold Corp.: Company History 14
Vista Gold Corp.: Management Statement 16
Vista Gold Corp.: Locations and Subsidiaries 18
Vista Gold Corp.: Key Competitors 19
Vista Gold Corp.: Company Analysis 20
Vista Gold Corp.: Business Description 20
Vista Gold Corp.: SWOT Analysis 21
Vista Gold Corp.: SWOT Overview 21
Vista Gold Corp.: Strengths 21
Vista Gold Corp.: Weaknesses 22
Vista Gold Corp.: Opportunities 22
Vista Gold Corp.: Threats 23
Vista Gold Corp.: Corporate Financial Deals Activity 24
Vista Gold Corp.: Financial Deals Overview 24
Vista Gold Corp.: Top Deals 2014 – 2018YTD* 26
Vista Gold Corp.: Divestments 27
Vista Gold Corp.: Recent Developments 28
Vista Gold Corp.: News and Events Summary 28
Vista Gold Corp.: Financial Performance 30
Vista Gold Corp.: Regulatory and Legal Events 31
Vista Gold Corp.: Strategy and Operations 31
Appendix 34
Contact Us 34
Methodology 34
About MarketLine 35

List of Tables
Table 1: Vista Gold Corp.: Key Facts
Table 2: Vista Gold Corp.: Key Employees
Table 3: Vista Gold Corp.: Locations and Subsidiaries
Table 4: Vista Gold Corp.: Key Competitors
Table 5: Vista Gold Corp.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vista Gold Corp.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Vista Gold Corp.: Top Deals 2014 - 2018YTD*
Table 8: Vista Gold Corp.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 9: Vista Gold Corp.: Divestments by Geography (2014 - YTD*2018)
Table 10: Vista Gold Corp.: News and Events Summary
Table 11: Vista Gold Corp.: Financial Performance
Table 12: Vista Gold Corp.: Regulatory and Legal Events
Table 13: Vista Gold Corp.: Strategy and Operations

List of Figures
Figure 1: Vista Gold Corp.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vista Gold Corp.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Vista Gold Corp.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 4: Vista Gold Corp.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Vista Gold Corp.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orlen Upstream Sp zoo:石油・ガス:M&Aディール及び事業提携情報
    Summary Orlen Upstream Sp zoo (Orlen Upstream), a subsidiary of Polski Koncern Naftowy Orlen SA is an oil and gas company that offers petroleum products and natural gas. The company provides products such as motor fuel, diesel, LPG, marine fuel, aviation fuel, greases, kerosene, brake fluids, techni …
  • W.H. Brakspear & Sons Limited:企業の戦略・SWOT・財務情報
    W.H. Brakspear & Sons Limited - Strategy, SWOT and Corporate Finance Report Summary W.H. Brakspear & Sons Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Hofseth Biocare ASA:企業の戦略・SWOT・財務情報
    Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report Summary Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Beiersdorf AG:企業の戦略・SWOT・財務情報
    Beiersdorf AG - Strategy, SWOT and Corporate Finance Report Summary Beiersdorf AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Safe Orthopaedics SA (SAFOR):企業の製品パイプライン分析2018
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • Zeus Co., Ltd. (079370):企業の財務・戦略的SWOT分析
    Zeus Co., Ltd. (079370) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • IOI Corporation Berhad:企業の戦略・SWOT・財務情報
    IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Acxiom Corporation:戦略・SWOT・企業財務分析
    Acxiom Corporation - Strategy, SWOT and Corporate Finance Report Summary Acxiom Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Group Five Ltd:企業の戦略的SWOT分析
    Group Five Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Coty Inc.:企業の戦略・SWOT・財務分析
    Coty Inc. - Strategy, SWOT and Corporate Finance Report Summary Coty Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Brookdale Senior Living Inc (BKD)-製薬・医療分野:企業M&A・提携分析
    Summary Brookdale Senior Living Inc (Brookdale) operates senior living communities which provide properties with high quality service, care and living accommodations for residents. The company focuses on providing an independent living, assisted living, dementia care, skilled nursing, continuing car …
  • Vodafone Group Plc (VOD):企業の財務・戦略的SWOT分析
    Vodafone Group Plc (VOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • United Surgical Partners International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary United Surgical Partners International Inc (United Surgical Partners) is a healthcare service provider that offers ambulatory surgical services. The center provides services in the therapeutical areas of orthopedic, pain management, gynaecology, general surgery, ear, nose, and throat, endosc …
  • Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheu …
  • Myriad RBM Inc-医療機器分野:企業M&A・提携分析
    Summary Myriad RBM Inc (Myriad RBM), formerly Rules Based Medicine Inc, a subsidiary of Myriad Genetics Inc, is an immunoassay testing laboratory that provides protein biomarker products and services. The company’s products and services include HumanMAP services that assist investigators in the disc …
  • Park City Group Inc (PCYG):企業の財務・戦略的SWOT分析
    Summary Park City Group Inc (Park City) is a technology company that provides supply chain, merchandising and store level solutions. The company offers scan based trading, vendor managed inventory, DSD visibility and strategic analysis, distribution center procurement, store level replenishment, ent …
  • The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C):企業の戦略・SWOT・財務情報
    The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C) - Strategy, SWOT and Corporate Finance Report Summary The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data …
  • ZIOPHARM Oncology Inc (ZIOP)-製薬・医療分野:企業M&A・提携分析
    Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to provides cell-based therapies for the treatment of cancer and graft-versus-host-disease …
  • North China Pharmaceutical Group Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary North China Pharmaceutical Group Corp (NCPC) is a healthcare products provider that manufactures and distributes formulation products, nutrition and health products, raw materials, and veterinary drugs. The company offers sirolimus capsules, clindamycin phosphate injection, mezlocillin sodiu …
  • SK Biopharmaceuticals Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a developer of drug candidates. The company develops and markets innovative drugs for the treatment of central nervous system. It offers plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆